Resonant Capital Advisors, LLC Biogen Inc. Transaction History

Resonant Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 26, 2022	SELL	$223.92 - $287.77 $787,078 - $1.01 Million	-3,515 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$282.99 - $369.05 $55,183 - $71,964	195 Added 5.87%	3,515 $995,000
Q2 2021 Jul 16, 2021	BUY	$259.0 - $414.71 $11,137 - $17,832	43 Added 1.31%	3,320 $1.15 Million
Q1 2021 Apr 28, 2021	BUY	$242.95 - $284.63 $28,425 - $33,301	117 Added 3.7%	3,277 $917,000
Q4 2020 Jan 15, 2021	BUY	$236.26 - $355.63 $133,014 - $200,219	563 Added 21.68%	3,160 $774,000
Q3 2020 Nov 03, 2020	BUY	$264.77 - $305.71 $341,288 - $394,060	1,289 Added 98.55%	2,597 $737,000
Q2 2020 Aug 05, 2020	BUY	$258.66 - $342.55 $11,381 - $15,072	44 Added 3.48%	1,308 $350,000
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $339,826 - $431,074	1,264 New	1,264 $400,000

1,049

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Resonant Capital Advisors, LLC with notifications on news.